02/01/2016RMIT released the pamphlet ‘ Japan’s Initiative for the Global Industrialization of Regenerative Medicine’.
Regenerative Medicine Industrialization Task Force (RMIT) has been established as a task force underForum for Innovative Regenerative Medicine (FIRM).
Japan has set up the most advanced legal and regulatory environment for industrialization of regenerative medicine and cell therapy since the progressive legislations that took place in the autumn of 2014. Encouraged by that, some of the FIRM member companies have volunteered to organize Regenerative Medicine Industrialization Task Force (RMIT) and organized an industrialization support team as its initiating activity.
This support team is meant to help wide spectrum of organizations such as established mega pharmas, emerging venture businesses, or thriving academia, domestic and overseas alike, resolving various bottlenecks that hinder prompt industrialization of regenerative medicine and cell therapy. Our ultimate goal is to serve patients who crave break-through therapies by accelerating application of the stateof-the-art medical technologies.
With respect to industrialization of regenerative medicine and cell therapy, our support team will provide responses to the following requests and inquiries.
Upon necessity, we support and connect clients to relevant FIRM member companies for them to collaborate to further tackle the problems.
The services provided by the support team are principally free of charge for the time being.
1) Inquiries on regulatory issues
2) Inquiries on procurement, purchase, or trial use of materials, consumables and/or equipment
3) Inquiries on procurement, purchase, or trial use of apparatuses, machines, and/or facility
4) Inquiries and/or requests relating to manufacture and quality assurance
5) Inquiries relating to clinical studies
6) Inquiries relating to clinical trials
7) Inquiries around application and commercialization of products, e.g., excellent medical clinics for collaboration
8) Requests and/or inquiries with any other aspects concerning industrialization of regenerative medicine and cell therapy
With the aim of the rapid pipeline commercialization of cellular and tissue-based products in regenerative medicine inside and outside of Japan, the construction of a system providing research support, services and response/request to consultation etc. is being promoted to allow for one-stop service from research and development to clinical trials in Tonomachi, Kawasaki City, which is the International Strategic Zone of Kanagawa Prefecture.
E-mail correspondence is encouraged for oversea clients due to the time difference.If you prefer to call us, our lines are open from 0900 to 1200 and 1300 to 1600 Japan Standard Time, Monday through Friday.
Phone: +81 3 3510 9621 (English) +81 3 3510 9620 (Japanese)
Regenerative Medicine Industrialization Task Force (RMIT) established in Forum for Innovative Regenerative Medicine (FIRM) will provide referral and information provision services in order to facilitate commercialization of regenerative medicine (the “Services”).
TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, THE SERVICES ARE PROVIDED ON “AS AVAILABLE” AND “WITH ALL FAULTS” BASIS AND PROVIDED WITHOUT WARRANTIES, CONDITIONS, REPRESENTATIONS OR GUARANTIES OF ANY KIND, EITHER EXPRESSED, IMPLIED, STATUTORY OR OTHERWISE, INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED WARRANTIES OR CONDITIONS OF MERCHANTABILITY, SATISFACTORY QUALITY, CORRECTNESS, COMPLETENESS, NONINFRINGEMENT OF ANY PARTY’S RIGHT OR FITNESS FOR A PARTICULAR PURPOSE. NO ORAL OR WRITTEN INFORMATION OR ADVICE GIVEN BY RMIT SHALL CREATE A WARRANTY.
After the provision of the Services, RMIT shall not be responsible for any process or result in discussion or negotiation between you and any referred party.
2-3-11, Nihonbashi Lifescience Building 6F, Nihonbashi-Honcho, Chuo-ku, Tokyo 103-0023, Japan
TEL : +81-3-3510-9621 (English)
・About 3-minute walk from Exit A6 of Mitsukoshi-Mae Station on Tokyo Metro Ginza Line/Hanzomon Line
・3-minute walk from Exit 5 of Shin-Nihonbashi Station on JR Sobu Line
・15-minute walk from East Exit of Kanda Station on JR Yamanote Line, Keihin-Tohoku Line, Chuo Line
E-mail correspondence using contact form below is encouraged for oversea clients due to the time difference.
If you prefer to call us, our lines are open from 0900 to 1200 and 1300 to 1600 Japan Standard Time, Monday through Friday.
Phone: +81 3 3510 9621 (English)
Please fill in each items and send us mail by click the accept bottom.We will reach out to you by mail in three business days.